There is an urgent need to better comprehend the pathobiology of COVID-19, its clinical implications and the threat of other novel viruses. This is the foundation of the American Lung Association’s inaugural COVID-19 and Respiratory Virus Research Award helping to advance research against emerging respiratory pathogens.
Announcing Our Awardees
The awardees for the COVID-19 and Respiratory Virus Research Award are funded at $100,000 a year for two years, these awards are exploring important avenues to reduce the burden experienced due to this virus:
These areas of focus—the immune system’s response, how the virus causes pathology and applying public health to help identify risk factors and how to reduce community spread—are important lynchpins in the ability to reduce the burden of COVID-19 in the U.S.
The Lung Association continues to fund innovative research through our annual awards and grants program which can include COVID-19 work (ALA, 2020).